Evidence map›Paper›PMID 36042020›Full record

Trial reportJournal of neurology2023

Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study.

Tim Woelfle, Silvan Pless, Oscar Reyes, Andrea Wiencierz, Anthony Feinstein, Pasquale Calabrese, Konstantin Gugleta, Ludwig Kappos, Johannes Lorscheider, Yvonne Naegelin

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04413032 (DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Feasibility Study), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04413032 nacompletednot on this map

DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Feasibility Study

TypeinterventionalSponsorResearch Center for Clinical Neuroimmunology and Neuroscience BaselRan2020 to 2021Enrolled62ConditionsMultiple SclerosisArmsDreaMS
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Motor fatigue and fatigability in early multiple sclerosis patients: an analysis of clinical, radiological and psychological underpinnings.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  6. Article
  7. Article
  8. Observational
  9. Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.Annals of clinical and translational neurology · 2025
    Observational
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Information from ecological momentary assessments lead to over-medicalization: Commentary.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tim WoelfleDepartment of Neurology and MS Center, University Hospital and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6279-4158
Silvan PlessDepartment of Neurology and MS Center, University Hospital and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9660-9077
Oscar ReyesHealios AG, Basel, Switzerland.ORCID http://orcid.org/0000-0003-0169-297X
Andrea WiencierzClinical Trial Unit, Department of Clinical Research, University Hospital, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-8786-7915
Anthony FeinsteinDepartment of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Canada.ORCID http://orcid.org/0000-0002-0132-0909
Pasquale CalabreseDepartment of Neurology and MS Center, University Hospital and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-3347-5187
Konstantin GugletaOphthalmology, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-3520-2791
Ludwig KapposResearch Center for Clinical Neuroimmunology and Neuroscience Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-4175-5509
Johannes Lorscheider *Department of Neurology and MS Center, University Hospital and University of Basel, Basel, Switzerland. johannes.lorscheider@usb.ch.ORCID http://orcid.org/0000-0003-1100-2506
Yvonne Naegelin *Department of Neurology and MS Center, University Hospital and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-1315-4100

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is an unmet need for reliable and sensitive measures for better monitoring people with multiple sclerosis (PwMS) to detect disease progression early and adapt therapeutic measures accordingly.

objectiveTo assess reliability of extracted features and meaningfulness of 11 tests applied through a smartphone application ("dreaMS").

methodsPwMS (age 18-70 and EDSS ≤ 6.5) and matched healthy volunteers (HV) were asked to perform tests installed on their smartphone once or twice weekly for 5 weeks. Primary outcomes were test-retest reliability of test features (target: intraclass correlation [ICC] ≥ 0.6 or median coefficient of variation [mCV] < 0.2) and reported meaningfulness of the tests by PwMS. Meaningfulness was self-assessed for each test on a 5-point Likert scale (target: mean score of > 3) and by a structured interview. CLINICALTRIALS: gov Identifier: NCT04413032.

resultsWe included 31 PwMS (21 [68%] female, mean age 43.4 ± 12.0 years, median EDSS 3.0 [range 1.0-6.0]) and 31 age- and sex-matched healthy volunteers. Out of 133 features extracted from 11 tests, 89 met the preset reliability criteria. All 11 tests were perceived as highly meaningful to PwMS.

conclusionThe dreaMS app reliably assessed features reflecting key functional domains meaningful to PwMS. More studies with longer follow-up are needed to prove validity of these measures as digital biomarkers in PwMS.

Indexed as

Mobile ApplicationsMultiple SclerosisAdolescentAdultAgedFeasibility StudiesFemaleHumansMaleMiddle AgedReproducibility of ResultsSmartphoneYoung AdultDigital biomarkersMobile healthMultiple sclerosisSmartphoneSmartwatch

Identifiers

PMID36042020
PMCPMC9427170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.